Valerie Morisset - 10 Mar 2023 Form 4 Insider Report for Eliem Therapeutics, Inc. (CLYM)

Role: EVP, R&D and CSO
Signature: /s/ Brian Woodard, Attorney-in-Fact
Issuer symbol: CLYM
Transactions as of: 10 Mar 2023
Net transactions value: +$523
Form type: 4
Filing time: 14 Mar 2023, 17:04:42 UTC
Previous filing: 02 Nov 2022
Next filing: 04 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELYM	Common Stock	Options Exercise	$510	+255,219	+170%	$0.002000^*	405,541	10 Mar 2023	Direct
transaction	ELYM	Common Stock	Options Exercise	$12.24	+61,191	+15%	$0.000200^*	466,732	10 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELYM	Stock Option (Right to Buy)	Options Exercise	$0	-255,219	-98%	$0.000000	5,431	10 Mar 2023	Common Stock	255,219	$0.002000	Direct	F1
transaction	ELYM	Stock Option (Right to Buy)	Options Exercise	$0	-61,191	-50%	$0.000000	61,190	10 Mar 2023	Common Stock	61,191	$0.000200	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of April 1, 2019 (the "April 2019 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the April 2019 Vesting Commencement Date thereafter (or if there is no corresponding day, on the last day of the month) for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the April 2019 Vesting Commencement Date.
F2	The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of February 26, 2021 (the "February 2021 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the February 2021 Vesting Commencement Date thereafter (or if there is no corresponding day, on the last day of the month) for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the February 2021 Vesting Commencement Date.

Content

The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of April 1, 2019 (the "April 2019 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the April 2019 Vesting Commencement Date thereafter (or if there is no corresponding day, on the last day of the month) for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the April 2019 Vesting Commencement Date.

The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of February 26, 2021 (the "February 2021 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the February 2021 Vesting Commencement Date thereafter (or if there is no corresponding day, on the last day of the month) for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the February 2021 Vesting Commencement Date.